Prosecution Insights
Last updated: April 19, 2026

Oyster Point Pharma Inc.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19169817 USE OF VARENICLINE FOR TREATING OCULAR CONDITIONS KASSA, TIGABU 1619 Final Rejection Apr 03, 2025

Managing Oyster Point Pharma Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month